2004
|
||
|---|---|---|
|
January
January; 53 (1): 1 - 121 |
February
February; 53 (2): 123 - 410 Supplement: Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent |
March
March; 53 (3): 411 - 553 |
|
April
April; 53 (4): 555 - 690 |
May
May; 53 (5): 691 - 893 Supplement: Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem |
June
June; 53 (6): 895 - 1115 |
|
July
July; 54 (1): 1 - 294 |
August
Supplement: PROTEKT US: results from the second year of this longitudinal surveillance study of antimicrobial resistance among respiratory tract pathogens isolated from paediatric and adult patients in the USA August; 54 (2): 295 - 578 |
September
September; 54 (3): 579 - 700 |
|
October
October; 54 (4): 701 - 848 |
November
November; 54 (5): 849 - 969 |
December
December; 54 (6): 971 - 1162 |